David Lee to Risk Assessment
This is a "connection" page, showing publications David Lee has written about Risk Assessment.
Connection Strength
0.080
-
Meduri CU, Reardon MJ, Lim DS, Howard E, Dunnington G, Lee DP, Liang D, Gooley R, O'Hair D, Ng MK, Walton A, Spargias K, Blackman D, Coisne A, Hildick-Smith D, De Gouy M, Chenoweth S, Kar S, McCarthy PM, Piazza N, Qasam A, Martin RP, Leon MB, Mack MJ, Adams DH, Bapat V. Novel Multiphase Assessment for Predicting Left Ventricular Outflow Tract Obstruction Before Transcatheter Mitral?Valve Replacement. JACC Cardiovasc Interv. 2019 12 09; 12(23):2402-2412.
Score: 0.031
-
Townsend RR, Mahfoud F, Kandzari DE, Kario K, Pocock S, Weber MA, Ewen S, Tsioufis K, Tousoulis D, Sharp ASP, Watkinson AF, Schmieder RE, Schmid A, Choi JW, East C, Walton A, Hopper I, Cohen DL, Wilensky R, Lee DP, Ma A, Devireddy CM, Lea JP, Lurz PC, Fengler K, Davies J, Chapman N, Cohen SA, DeBruin V, Fahy M, Jones DE, Rothman M, B?hm M. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet. 2017 Nov 11; 390(10108):2160-2170.
Score: 0.026
-
Kereiakes DJ, Yeh RW, Massaro JM, Driscoll-Shempp P, Cutlip DE, Steg PG, Gershlick AH, Darius H, Meredith IT, Ormiston J, Tanguay JF, Windecker S, Garratt KN, Kandzari DE, Lee DP, Simon DI, Iancu AC, Trebacz J, Mauri L. Stent Thrombosis in Drug-Eluting or Bare-Metal?Stents in Patients Receiving Dual?Antiplatelet?Therapy. JACC Cardiovasc Interv. 2015 Oct; 8(12):1552-62.
Score: 0.023